Your browser doesn't support javascript.
loading
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.
Cambron, Melissa; Mostert, Jop; D'Hooghe, Marie; Nagels, Guy; Willekens, Barbara; Debruyne, Jan; Algoed, Luc; Verhagen, Wim; Hupperts, Raymond; Heersema, Dorothea; De Keyser, Jacques.
Afiliação
  • Cambron M; Department of Neurology, UZ Brussel, Brussel, Belgium/Center for Neurosciences (C4N) Vrije Universiteit Brussel (VUB), Brussels, Belgium/ Department of Neurology, AZ Sint-Jan, Bruges, Belgium.
  • Mostert J; Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands.
  • D'Hooghe M; Department of Neurology, UZ Brussel, Brussel, Belgium/Center for Neurosciences (C4N) Vrije Universiteit Brussel (VUB), Brussels, Belgium/Nationaal MS Centrum Melsbroek, Steenokkerzeel, Belgium.
  • Nagels G; Department of Neurology, UZ Brussel, Brussel, Belgium/Center for Neurosciences (C4N) Vrije Universiteit Brussel (VUB), Brussels, Belgium/Nationaal MS Centrum Melsbroek, Steenokkerzeel, Belgium.
  • Willekens B; Department of Neurology, University Hospital Antwerp, Antwerp, Belgium.
  • Debruyne J; Department of Neurology, University Hospital Gent, Gent, Belgium.
  • Algoed L; Department of Neurology, AZ Maria Middelares, Gent, Belgium.
  • Verhagen W; Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Hupperts R; Department of Neurology, Zuyderland Medisch Centrum, Sittard-Geleen, The Netherlands.
  • Heersema D; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • De Keyser J; Department of Neurology, UZ Brussel, Brussel, Belgium/Center for Neurosciences (C4N) Vrije Universiteit Brussel (VUB), Brussels, Belgium/ Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Mult Scler ; 25(13): 1728-1735, 2019 11.
Article em En | MEDLINE | ID: mdl-31218911

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluoxetina / Inibidores Seletivos de Recaptação de Serotonina / Esclerose Múltipla Crônica Progressiva Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluoxetina / Inibidores Seletivos de Recaptação de Serotonina / Esclerose Múltipla Crônica Progressiva Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bélgica